Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersMarco Ladetto, Christiane Pott, Monika Brüggemann et al.|Leukemia|2013Cited by 305
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted MyelomaMarco Ladetto, Antonio Palumbo, G Pagliano et al.|Journal of Clinical Oncology|2010Cited by 268
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPatrizia Pregno, Umberto Vitolo, Annalisa Chiappella et al.|Blood|2012Cited by 238
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular LymphomaDaniela Drandi, Marco Ladetto, Lenka Kubiczkova-Besse et al.|Journal of Molecular Diagnostics|2015Cited by 132
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaDavide Rossi, Marco Ladetto, Chiara Lobetti Bodoni et al.|Leukemia|2009Cited by 98